A Review on Current Trends in the Management of Ebola Virus Disease | Abstract

International Journal of Pharmacy Teaching & Practices

ISSN - 1986-8111


A Review on Current Trends in the Management of Ebola Virus Disease

Palanisamy Sivanandy, Shim Hui Sin, Ong Yee Ching, Dayalini Rajasekar, Gan Sau Woon, Hii Hieng Chiew, Charisse Ng Ee-Yenn, Khoo Xin Wei, Yeap Wei Leng.

The Ebola virus created a ripple of fear when its number of cases rose rapidly and drastically in recent years. Ebola infection is transmitted in humans when contact closely with blood, organs or other body fluids of infected animals or secretions. It is often mortal as it affects vascular system of the body which simply denotes the ways blood travels throughout the body. Hence, this results in organ failure and serious internal bleeding. Standard supporting care in a hospital setting such as replenishment of fluid and electrolytes, ventilation support, pain control and nutritional support is initiated to the patients to manage the symptoms and prevent any complications of Ebola disease since there are no FDA-approved medications available. In terms of pharmacological drug therapy, Favipiravir has been shown to be efficacious and safe in treating the Ebola Virus Disease (EVD). Nevertheless, there are some preventive measures as well to decrease the risk of getting the disease.